Efficacy of VALERGENT-BT subcutaneous vaccine in asthmatic adults |
99mTc-marked 14F7 MaB in metastatic breast, phase II |
14F7 MAb marked with Tc99 Phase II in breast tumors. |
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment. |
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma. |
THERESA |
Autologous graft in extensive myomectomies |
Gallbladder retractor and Knot pusher with simultaneous coaxial traction : new laparoscopic instruments. |
THERESA-2 Study |
CIGB500 in healthy volunteers |
Patients with non small cells lung cancer (NSCLC) and brain metastasis. |
NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II. |
h-R3 MAb combined with radio chemotherapy to treat non-surgical esophagus tumors of epithelial origin. |
Intraoperative endoscopic retrograde sphincterotomy as a modality of treatment of choledocholithiasis |
hR3 MaB and radiotherapy in highly malignant astrocytic tumors, phase III. |
h-R3 MaB and radiotherapy in pediatric patients with intrinsic diffuse astrocytomas of brain stem, phase II. |
Anti-idiotype 1E10 vaccine in the treatment of patients with small cell lung (SCLC) patients |
Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patients |
1E10 anti-idiotype vaccine, metastatic breast cancer, phase II |
Toxicological evaluation of the humanized Anti-CD6 MAb T1h in Rheumatoid Arthritis Patients |